[New therapeutic possibilities in fibrinolytic syndromes].
D000963:Antimetabolites; D005260:Female; D005342:Fibrinolysis; D006470:Hemorrhage; D006801:Humans; D007610:Kallikreins; D008796:Metrorrhagia; D010447:Peptide Hydrolases; D006473:Postpartum Hemorrhage; D049590:Postpartum Period; D013577:Syndrome; D014592:Uterine Hemorrhage
D000963:Antimetabolites; D010447:Peptide Hydrolases; D007610:Kallikreins
ANTIMETABOLITES; FIBRINOLYSIS; HEMORRHAGE, POSTPARTUM; KALLIKREIN; METRORRHAGIA; PEPTIDE HYDROLASES; UTERINE HEMORRHAGE